Back to search
Neutropenia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neutropenia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neutropenia trials you may qualify forUndergoing cancer treatment comes with various risks and side effects. This clinical trial aims to reduce those risks and side effects through continuous monito…
The goal of this clinical trial is to evaluate the efficacy and safety of Telpegfilgrastim (a PEGylated recombinant human granulocyte colony-stimulating factor,…
Background: * WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is caused by various genetic changes that increase the activity of t…
This study is a multicenter, single-arm, open-label Phase II exploratory clinical trial designed to evaluate whether prophylactic use of leucogen can reduce the…
Antibacterial prophylaxis is recommended in patients at high risk of infection, specifically patients undergoing acute leukemia induction therapy or hematopoiet…
The purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired pri…
The purpose of this study is to find out whether letermovir can help prevent cytomegalovirus (CMV) infection in kidney transplant recipients who are CMV seropos…
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects complet…
Chemotherapy-induced febrile neutropenia (CIFN) is a dangerous complication of many chemotherapy drugs, with current treatment with granulocyte colony-stimulati…